Yoon et al. previously reported on a CRP-based point-of-care screening test for TB (89% sensitivity and 72% specificity with a pre-determined threshold of 10mg/L) in antiretroviral therapy-naive, HIV-infected individuals with low CD4-cell counts from Uganda (22). This evidence concerns the gene CRP and tuberculosis.